Form 8-K - Current report:
SEC Accession No. 0001193125-24-160339
Filing Date
2024-06-13
Accepted
2024-06-13 09:06:31
Documents
18
Period of Report
2024-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d814183d8k.htm   iXBRL 8-K 31712
2 EX-1.1 d814183dex11.htm EX-1.1 248499
3 EX-5.1 d814183dex51.htm EX-5.1 39640
4 EX-10.1 d814183dex101.htm EX-10.1 53723
5 EX-99.1 d814183dex991.htm EX-99.1 9541
9 GRAPHIC g814183g55h99.jpg GRAPHIC 2441
  Complete submission text file 0001193125-24-160339.txt   609255

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA prok-20240611.xsd EX-101.SCH 2514
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE prok-20240611_lab.xml EX-101.LAB 18699
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prok-20240611_pre.xml EX-101.PRE 11686
21 EXTRACTED XBRL INSTANCE DOCUMENT d814183d8k_htm.xml XML 3872
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 241040112
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)